Bone Graft Composition Viscosity Control via Methylcellulose Additive

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing bone graft compositions face limitations in biocompatibility, viscosity, and shape retainability, which affect their effectiveness in bone regeneration and stability during surgical procedures.

Innovation Solution

A bone graft composition is developed containing a bone graft material and a methylcellulose-based additive, such as hydroxypropyl methylcellulose, with a viscosity range of 100 to 500,000 centipoises, enhancing biocompatibility and shape retainability by adjusting the additive's content to 0.03 to 3 parts by weight based on the bone graft material.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional bone graft materials are used, then bone regeneration can be achieved, but viscosity control and shape retainability are limited

Engineering Contradiction:
Improvebone regeneration effectivenessVSAvoidviscosity control and shape retainability
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent applies parameter changes by systematically adjusting the viscosity of the bone graft composition through controlled addition of methylcellulose-based additives. The viscosity is optimized to a specific range (100-500,000 cps) to simultaneously achieve ease of application and shape retainability. This parameter optimization resolves the contradiction by finding the optimal viscosity window that satisfies both operational ease and structural stability requirements.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite material system by combining bone graft materials (such as calcium phosphate compounds) with methylcellulose-based additives. This composite approach allows the composition to exhibit both the osteogenic properties of bone graft materials and the rheological control provided by the cellulose derivative, thereby achieving both effective bone regeneration and improved viscosity control with shape retainability.

Inventive Principle:
Principle #40Composite materials

2Shape

If additive content is increased to improve viscosity, then shape retainability improves, but biocompatibility may be affected

Engineering Contradiction:
Improveshape retainabilityVSAvoidbiocompatibility
Core Design Contradiction:
ShapeVSObject-affected harmful factors

Solution Approach 1:

The patent resolves this contradiction through precise parameter control by limiting the additive content to a specific range (0.03-3 parts by weight per part of bone graft material). This controlled parameter adjustment ensures that viscosity and shape retainability are improved while maintaining biocompatibility, as the additive concentration remains within safe and effective boundaries.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs methylcellulose-based additives that are biodegradable and temporarily functional. These additives provide the necessary viscosity and shape control during the surgical procedure and initial setting phase, then gradually degrade in the body, eliminating long-term biocompatibility concerns while achieving the required short-term structural support.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition achieves optimal viscosity and shape retention, ensuring effective bone formation, biocompatibility, and ease of use by maintaining structural integrity during mastication and hydration processes.

Implementation Method 1

the additive includes only a methylcellulose-based additive and the viscosity of the bone graft composition is 100 to 500,000 centipoise (cps)

Methodology Applied
Scientific EffectViscosity enhancement through hydrocolloid additive:

Data Source

PatentEP4000658A1Bone graft composition
Publication Date: 2022.05.25 MEDPARK CO LTD
  • EP4000658A1 patent drawingFigure 1
  • EP4000658A1 patent drawingFigure 2
  • EP4000658A1 patent drawingFigure 3

AI summary

The present disclosure relates to a bone graft composition containing a bone graft material and an additive and having a predetermined viscosity, wherein the additive includes only a methylcellulose-based additive, and a viscosity of the bone graft composition is 100 to 500,000 centipoises (cps).